• <em>NSD1</em> Inactivation and <em>SETD2</em> Mutation Drive a Convergence toward Loss of Function of H3K36 Writers in Clear Cell Renal Cell Carcinomas
• <em>UGT1A1</em> mutations and psychoses: towards understanding the relationship with unconjugated bilirubin
• <em>UGT1A1</em> Variants c.864+5G&gt;T and c.996+2_996+5del of a Crigler-Najjar Patient Induce Aberrant Splicing in Minigene Assays
• <em>UGT1A1</em>-related Bilirubin Encephalopathy/Kernicterus in Adults
• A case report of a novel 22 bp duplication within exon 1 of the UGT1A1 in a Sudanese infant with Crigler-Najjar syndrome type I
• A family study of the compound heterozygous mutation of the <em>UGT1A1</em> gene causing Crigler-Najjar syndrome type II
• A novel deletion with two pathogenic variants of UGT1A1 causing Crigler-Najjar syndrome in two unrelated Chinese
• A Novel Pathogenic <em>UGT1A1</em> Variant in a Sudanese Child with Type 1 Crigler-Najjar Syndrome
• A novel UGT1A1 gene mutation causing severe unconjugated hyperbilirubinemia: a case report
• A Quantitative <em>In Vitro</em> Potency Assay for Adeno-Associated Virus Vectors Encoding for the <em>UGT1A1</em> Transgene
• A Rare Case Report of Crigler Najjar Syndrome Type II
• AAV8 Gene Therapy for Crigler-Najjar Syndrome in Macaques Elicited Transgene T Cell Responses That Are Resident to the Liver
• AAV8 Gene Therapy Rescues the Newborn Phenotype of a Mouse Model of Crigler-Najjar
• ABO-incompatible Pediatric Liver Transplantation With Antibody and B-cell Depletion-free Immunosuppressive Protocol in High Consanguinity Communities
• Analysis of mutation site characteristics of Gilbert syndrome and Crigler--Najjar syndrome in relation to uridine diphosphate glucuronosyltransferase A1 gene
• Atrial fibrillation in older adults with cancer
• Auxiliary Partial Orthotopic Liver Transplantation for Monogenic Metabolic Liver Diseases: Single-Centre Experience
• Bilirubin metabolism and UDP-glucuronosyltransferase 1A1 variants in Asians: Pathogenic implications and therapeutic response
• Carbon monoxide breath test assessment of mild hemolysis in Gilbert's syndrome
• Case report: multiple UGT1A1 gene variants in a patient with Crigler-Najjar syndrome
• Clinical and pathological features of inherited metabolic liver disease in adults
• Combined Spinal and TAP Blocks for Laparoscopic Cholecystectomy for a Patient with Crigler-Najjar Type 2: A Case Report
• Comparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders
• CORRIGENDUM: Quantitative Systems Pharmacology Model of hUGT1A1-modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler-Najjar Syndrome Type 1
• Crigler Najjar Syndrome Type 2 (CNS Type 2): An Unwonted Cause of Jaundice in Adults
• Crigler-Najjar Syndrome
• Crigler-Najjar Syndrome Type 1: Pathophysiology, Natural History, and Therapeutic Frontier
• Crigler-Najjar Syndrome Type II Diagnosed in a Patient with Jaundice Since Birth
• Crigler-Najjar Syndrome: Current Perspectives and the Application of Clinical Genetics
• Determining the Minimally Effective Dose of a Clinical Candidate AAV Vector in a Mouse Model of Crigler-Najjar Syndrome
• Diagnostic criteria and contributors to Gilbert's syndrome
• Differences in UGT1A1 gene mutations and pathological liver changes between Chinese patients with Gilbert syndrome and Crigler-Najjar syndrome type II
• Diffusion Tensor Imaging of Auditory Pathway in Patients With Crigler-Najjar Syndrome Type I: Correlation With Auditory Brainstem Response
• Diffusion Tensor Imaging of Microstructural Changes in the Gray and White Matter in Patients With Crigler-Najjar Syndrome Type I
• Disease burden and management of Crigler-Najjar syndrome: Report of a world registry
• Disease burden of Crigler-Najjar syndrome: Systematic review and future perspectives
• Early identification of heart failure deterioration through respiratory monitoring with adaptive servo-ventilation
• Effects of Different Cold Preservation Solutions on the Functions of Cultured Isolated Human Hepatocytes
• Efficacy of AAV8-h<em>UGT1A1</em> with Rapamycin in neonatal, suckling, and juvenile rats to model treatment in pediatric CNs patients
• Efficacy of Immune Checkpoint Inhibitors in Upper Tract Urothelial Carcinomas: Current Knowledge and Future Directions
• Extended Family Outreach in Hereditary Cancer Using Web-Based Genealogy, Direct-to-Consumer Ancestry Genetics, and Social Media: Mixed Methods Process Evaluation of the ConnectMyVariant Intervention
• Frailty as a Predictor of Mortality in Patients With Interstitial Lung Disease Referred for Lung Transplantation
• Frailty in lung transplantation: a systematic review
• Gene Therapy in Patients with the Crigler-Najjar Syndrome
• Generation of a Crigler-Najjar Syndrome Type I patient-derived induced pluripotent stem cell line CNS705 (HHUUKDi005-A)
• Genes and Pathways Promoting Long-Term Liver Repopulation by <em>Ex Vivo </em>hYAP-ERT2 Transduced Hepatocytes and Treatment of Jaundice in Gunn Rats
• Genetic landscape of indolent and aggressive Kaposi sarcomas
• Genetic testing of UGT1A1 in the diagnosis of Gilbert syndrome: The discovery of seven novel variants in the Chinese population
• Gilbert or Crigler-Najjar syndrome? Neonatal severe unconjugated hyperbilirubinemia with P364L UGT1A1 homozygosity
• Gilbert Syndrome
• Gilbert Syndrome and Genetic Findings in Children: A Tertiary-Center Experience from Turkey
• Hepatic Parenchymal Injury in Crigler-Najjar Type I
• Human liver stem cells express UGT1A1 and improve phenotype of immunocompromised Crigler Najjar syndrome type I mice
• Induction of fecal cholesterol excretion is not effective for the treatment of hyperbilirubinemia in Gunn rats
• Inflammatory signature of cerebellar neurodegeneration during neonatal hyperbilirubinemia in Ugt1 ^-/- mouse model
• Lipid nanoparticle-encapsulated mRNA therapy corrects serum total bilirubin level in Crigler-Najjar syndrome mouse model
• Liver Cirrhosis in a Patient with Crigler Najjar Syndrome
• Liver Fibrosis Associated With Crigler-Najjar Syndrome in a Compound Heterozygote: A Case Report
• Liver histologic changes in children with type 1 of Crigler-Najjar syndrome
• Liver Transplantation in a Child With Crigler-Najjar Syndrome Type I: A Case Report With Review of the Literature
• Management of Crigler-Najjar syndrome
• MRI in predicting conversion to multiple sclerosis within 1 year
• Neuro-inflammatory effects of photodegradative products of bilirubin
• Novel <em>UGT1A1</em> Gene Mutations in a Boy with Crigler-Najjar Syndrome Type II
• Novel combined UGT1A1 mutations in Crigler Najjar Syndrome type I
• Novel mutations in Uridyl-diphosphate-glucuronosyl-transferase 1A1 (UGT1A1) gene in Tunisian patients with unconjugated hyperbilirubinemia
• Oral findings in Crigler-Najjar syndrome type I
• Outcome of liver transplantation and prevalence of liver fibrosis in Crigler-Najjar syndrome
• p.Cys223Tyr mutation causing Crigler-Najjar syndrome type II
• Paternal uniparental disomy of chromosome 2 resulting in a concurrent presentation of Crigler-Najjar syndrome type I and long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency
• Perioperative Management of Patient with Esophageal Carcinoma and Crigler-Najjar Syndrome Type 2: A Case Report
• Phase I/II Trial of Liver-derived Mesenchymal Stem Cells in Pediatric Liver-based Metabolic Disorders: A Prospective, Open Label, Multicenter, Partially Randomized, Safety Study of One Cycle of Heterologous Human Adult Liver-derived Progenitor Cells (Hepa
• Photophysical Mechanisms of Photobiomodulation Therapy as Precision Medicine
• Preclinical Development of an AAV8-hUGT1A1 Vector for the Treatment of Crigler-Najjar Syndrome
• Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler-Najjar Syndrome
• Promoterless gene targeting without nucleases rescues lethality of a Crigler-Najjar syndrome mouse model
• Quantitative Systems Pharmacology Model of hUGT1A1-modRNA Encoding for the UGT1A1 Enzyme to Treat Crigler-Najjar Syndrome Type 1
• Real-life Progression of the Use of a Genetic Panel in to Diagnose Neonatal Cholestasis
• Regenerative cell therapy for the treatment of hyperbilirubinemic Gunn rats with fresh and frozen human induced pluripotent stem cells-derived hepatic stem cells
• Renal cell carcinoma in children and adolescents: a retrospective study of a French-Italian series of 93 cases
• Repeated AAV-mediated gene transfer by serotype switching enables long-lasting therapeutic levels of hUgt1a1 enzyme in a mouse model of Crigler-Najjar Syndrome Type I
• Response: Commentary: Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances
• SARS-CoV-2 BA.2 (Omicron) variant infection in pediatric liver transplanted recipients and cohabitants during 2022 Shanghai outbreak: a prospective cohort
• Severe Neonatal Hyperbilirubinemia in Crigler-Najjar Syndrome Model Mice Can Be Reversed With Zinc Protoporphyrin
• Spectrum of UGT1A1 variants in Pakistani children affected with inherited unconjugated hyperbilirubinemias
• Study on spectrum of UGT1A1 mutations in connection with inherited non-hemolytic unconjugated hyperbilirubinemia
• Successful living donor liver transplantation plus domino-auxiliary partial orthotopic liver transplantation for pediatric patients with metabolic disorders
• The added value of brain MR spectroscopy in children with Crigler-Najjar syndrome type-I: correlation with demographic, neurodevelopmental, and laboratory findings
• The First Two Liver Transplantations in Syria
• The network structure of mania symptoms differs between people with and without binge eating
• The relationship between <em>UGT1A1</em> gene &amp; various diseases and prevention strategies
• Translational research for bone marrow failure patients
• Transplanted Human Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Support Liver Regeneration in Gunn Rats
• UGT1A1 genotypes and unconjugated hyperbilirubinemia phenotypes in post-neonatal Chinese children: A retrospective analysis and quantitative correlation
• UGT1A1 polymorphisms in cancer: impact on irinotecan treatment
• Ultrasound-guided in Utero Transplantation of Placental Stem Cells into the Liver of Crigler-Najjar Syndrome Model Rat
• Unusual Indications for a Liver Transplant: A Single-Center Experience
• Update on a previously reported missense mutation: The c.1160 C&gt;A mutation in the UGT1A1 gene result in Crigler-Najjar syndrome type 1
• Variants Associated with Infantile Cholestatic Syndromes Detected in Extrahepatic Biliary Atresia by Whole Exome Studies: A 20-Case Series from Thailand
• What's next in gene therapy for Crigler-Najjar syndrome?